Cardiomyopathy is a group of diseases that affect the structure and function of the heart muscle, primarily characterized by decreased myocardial contractility or ventricular dilation, leading to impaired cardiac pumping function. There are many types of this disease, including dilated, hypertrophic, and restrictive cardiomyopathies, with dilated cardiomyopathy being the most common. Cardiomyopathy may be triggered by genetic, infectious, or environmental factors. Severe cases can lead to heart failure, arrhythmias, or even sudden death.
Modern medicine has developed various diagnostic and treatment strategies for cardiomyopathy, including medication management, implantation of cardiac devices, and surgical interventions. Early diagnosis and active management can significantly delay disease progression and improve patients' quality of life. This article will comprehensively analyze key information about cardiomyopathy, including causes, symptoms, diagnostic methods, treatment, and prevention measures.
Approximately 30% to 50% of dilated cardiomyopathy cases are associated with genetic mutations, with the most common genes including TNNI3, TNNC1, and LMNA. These genes encode proteins necessary for myocardial contraction, and mutations can lead to abnormal myocardial cell structure. Familial cardiomyopathy is usually inherited in an autosomal dominant pattern, but phenotypic severity can vary among individuals.
Viral infections such as coxsackievirus or HIV can induce myocarditis and progress to dilated cardiomyopathy. Long-term alcohol abuse or drug misuse (such as opioids or amphetamines) can also directly damage myocardial tissue. Additionally, chronic hypertension, coronary artery disease, or iron overload syndromes (e.g., hemochromatosis) can indirectly lead to abnormal myocardial structure.
Patients who have undergone cardiac radiation therapy have a 10% to 20% chance of developing myocardial damage within 5 to 10 years post-treatment. Such patients require long-term cardiac function monitoring.
In the early stages, patients may experience only mild discomfort, commonly presenting as shortness of breath during exertion, occasional chest tightness, or palpitations. Some patients may experience orthopnea (difficulty breathing when lying flat), related to decreased cardiac output leading to pulmonary congestion.
As the disease advances to a moderate stage, patients may develop persistent fatigue, lower limb edema, abdominal distension (due to portal hypertension), and paroxysmal nocturnal dyspnea. Severe cases may exhibit arrhythmias such as atrial fibrillation or ventricular tachycardia, increasing the risk of stroke or sudden death.
Transthoracic echocardiography is the primary diagnostic tool, measuring the degree of ventricular dilation and systolic function indices (such as left ventricular ejection fraction <35% meeting diagnostic criteria). Cardiac magnetic resonance imaging (MRI) can more accurately assess myocardial fibrosis and regional motion abnormalities.
Electrocardiography can detect arrhythmic signs, such as QT prolongation or ST segment changes. Cardiac catheterization assesses coronary artery blood flow and ventricular pressures, aiding in the differential diagnosis of coronary artery disease. Blood tests showing elevated cardiac enzymes (such as troponin) indicate myocardial injury.
Angiotensin-converting enzyme inhibitors (ACEI) and beta-blockers are foundational treatments. ACEI reduce afterload, while beta-blockers decrease myocardial oxygen consumption. Diuretics are used to relieve edema, and anticoagulants (such as warfarin) are used in patients with atrial dilation to prevent stroke.
Cardiac resynchronization therapy (CRT) devices can improve ventricular synchrony, and implantable cardioverter defibrillators (ICD) can promptly treat life-threatening arrhythmias. Patients with severe heart failure may require heart transplantation, with approximately 5% to 10% of end-stage patients undergoing this procedure annually worldwide.
A low-sodium diet (less than 2000 mg of salt daily) effectively controls edema. Smoking cessation and alcohol restriction are crucial; studies show that daily alcohol intake exceeding 30 grams increases heart failure risk by threefold. Regular aerobic exercise should be evaluated by a physician, typically recommended at 60-70% target heart rate for short durations.
Patients with genetic cardiomyopathy should undergo genetic counseling, and family members should have regular cardiac imaging screening. Managing metabolic conditions such as diabetes and hyperlipidemia can reduce the risk of developing cardiomyopathy. Vaccinations against influenza and pneumonia can decrease the chance of infections that trigger myocarditis.
If you experience persistent chest pain, unexplained weight gain of 2 kg within 24 hours, resting heart rate over 100 bpm, or shortness of breath during daily activities, seek medical attention immediately. Patients with a history of heart disease presenting with angina or syncope should be treated as emergencies.
Even if symptoms occur intermittently (such as occasional dizziness or mild lower limb edema), prompt cardiac evaluation is recommended. Doctors may suggest hospitalization for observation or 24-hour Holter monitoring to assess arrhythmia risk.
Patients should avoid foods high in salt, fat, and sugar to reduce cardiac burden. It is recommended to increase intake of omega-3-rich deep-sea fish, high-fiber vegetables, and whole grains, while controlling total calorie intake to maintain a healthy weight. For those with edema or hypertension, strict salt restriction and regular consultation with a nutritionist for personalized dietary plans are advised.
Are there special considerations for physical activity in cardiomyopathy patients?Patients should avoid strenuous exercise and high-intensity interval training. Low to moderate aerobic activities such as walking, swimming, or yoga are recommended after medical evaluation. Monitoring heart rate and fatigue during exercise is important; stop immediately if chest pain, dizziness, or shortness of breath occurs, and seek medical attention.
Is cardiomyopathy entirely caused by genetic factors?Approximately 30-50% of cardiomyopathy cases are related to genetic mutations, but many cases are triggered by acquired factors such as long-term hypertension, cardiac infections, or metabolic diseases. Genetic testing can confirm hereditary cardiomyopathy, but non-genetic cases should focus on treating the primary disease. A comprehensive evaluation of the cause is essential after diagnosis.
Is it safe for cardiomyopathy patients to use herbal medicines or supplements?Some herbal medicines may interfere with cardiac drug metabolism or directly affect myocardial function. For example, ingredients containing ephedrine may induce arrhythmias. Patients should consult their physicians before using any herbal remedies, vitamins, or supplements, and disclose all current medications to avoid interactions.
Can cardiomyopathy patients travel by airplane safely?Patients with mild symptoms can undertake short flights with physician approval, but should be aware that cabin dryness may increase the risk of blood clots. Staying well-hydrated and moving limbs regularly during the flight are recommended. Patients with severe heart failure or recent complications should avoid long-haul flights, carry medical documentation, and inform airlines of special needs to ensure assistance in emergencies.
%201.svg)
Copyright © 2025 MedFrontiers. All Rights Reserved.
